vwf1 | 20371
Von Willebrand screen complete
Keywords:
Bleeding
Hemophilia
Status
| Material |
|
||
|---|---|---|---|
| Hint |
Please observe special preanalytical conditions. |
||
| Min. volume | 4.5 mL | ||
| Stability |
Stability
1 day / 18-25°C
|
||
| Duration | 2 weeks | ||
| Frequency | 1 x per week | ||
| Method | Immunologisch und funktionell |
Price/Rate
| Price |
Price
CHF 189.40
|
|---|---|
| Rate |
Rate
189.40 TP
|
Single Analysis
| Kell Antigen | bgk | Blood EDTA |
|---|---|---|
| Rhesus phenotype | bg3 | Blood EDTA |
| Rhesus D | bg2 | Blood EDTA |
| Blood group AB0 | bg1 | Blood EDTA |
| vWF Antigen | viiia | Plasma citrate |
| vWF-Activity | viiir | Plasma citrate |
| FactorVIII hemophilia A | viiic | Plasma citrate |
| Hematogram II | bb2 | Blood EDTA |
